HLS: Directors' Statement re Takeover
|
23 May 2023 at 9:35am
|
Response to Healius' Target's Statement
|
22 May 2023 at 10:25am
|
Second Supplementary Bidder's Statement
|
22 May 2023 at 10:05am
|
Takeover offer - receipt of Target's Statement
|
5 May 2023 at 9:30am
|
HLS: Lodgement of Target's Statement
|
4 May 2023 at 9:20am
|
Completion of dispatch of replacement bidder's statement
|
21 April 2023 at 7:20pm
|
Commencement of dispatch of replacement bidder's statement
|
21 April 2023 at 6:15pm
|
Notice of EGM
|
20 April 2023 at 12:45pm
|
TOV: HLS Panel Declines to Conduct Proceedings
|
17 April 2023 at 10:20am
|
ASX announcement - Replacement Bidder's Statement
|
14 April 2023 at 6:30pm
|
Replacement Bidder's Statement
|
14 April 2023 at 6:30pm
|
First Supplementary Bidder's Statement
|
14 April 2023 at 6:20pm
|
Change in substantial holding
|
29 March 2023 at 2:50pm
|
Change in substantial holding
|
29 March 2023 at 11:30am
|
TOV: HLS Panel Receives Application
|
29 March 2023 at 10:25am
|
Update - Dividend/Distribution - ACL
|
28 March 2023 at 10:50am
|
Becoming a substantial holder
|
27 March 2023 at 6:40pm
|
Suspension of DRP
|
27 March 2023 at 4:10pm
|
HLS: Directors' Statement re Takeover
|
27 March 2023 at 9:00am
|
Proposed issue of securities - ACL
|
22 March 2023 at 4:25pm
|
Becoming a substantial holder for HLS
|
20 March 2023 at 10:45am
|
People to whom information is to be sent
|
20 March 2023 at 10:45am
|
HLS: Off-market takeover bid from ACL
|
20 March 2023 at 10:20am
|
Investor Webinar - Takeover Offer for Healius
|
20 March 2023 at 8:55am
|
Investor Presentation - Takeover Offer for Healius
|
20 March 2023 at 8:55am
|
Bidder's Statement in relation to Takeover Offer for Healius
|
20 March 2023 at 8:55am
|
Takeover Offer for Healius Limited
|
20 March 2023 at 8:55am
|
Notification regarding unquoted securities - ACL
|
17 March 2023 at 6:25pm
|
Change of Director's Interest Notice
|
17 March 2023 at 6:15pm
|
Notification regarding unquoted securities - ACL
|
17 March 2023 at 6:10pm
|
Notification of cessation of securities - ACL
|
17 March 2023 at 6:05pm
|
Ceasing to be a substantial holder
|
22 February 2023 at 11:45am
|
Dividend/Distribution - ACL
|
20 February 2023 at 8:30am
|
1H23 results investor presentation
|
20 February 2023 at 8:30am
|
Appendix 4D and 1H23 financial reports
|
20 February 2023 at 8:30am
|
1H23 Financial Results release details
|
13 February 2023 at 10:45am
|
Release of Shares from Voluntary Escrow
|
9 February 2023 at 4:05pm
|
Medlab Cyber Incident Update
|
5 December 2022 at 8:45am
|
Ceasing to be a substantial holder
|
22 November 2022 at 5:20pm
|
Becoming a substantial holder
|
11 November 2022 at 5:30pm
|
Medlab Pathology Cyber Incident
|
27 October 2022 at 8:40am
|
2022 AGM - Results of Meeting
|
19 October 2022 at 11:55am
|
2022 AGM - addresses to shareholders
|
19 October 2022 at 10:10am
|
Change of Director's Interest Notice
|
7 October 2022 at 4:10pm
|
Director Appointment/Resignation
|
7 October 2022 at 4:10pm
|
Change of Director's Interest Notice
|
27 September 2022 at 12:20pm
|
Change of Director's Interest Notice
|
20 September 2022 at 11:05am
|
Ceasing to be a substantial shareholder
|
16 September 2022 at 11:05am
|
2022 Annual Report and Corporate Governance Statement
|
16 September 2022 at 8:45am
|
Appendix 4G
|
16 September 2022 at 8:45am
|